{"nct_id":"NCT04623216","title":"Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.","status":"TERMINATED","status_verified_date":"2025-06","start_date":"2021-09-14","start_date_type":"ACTUAL","primary_completion_date":"2024-08-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-22","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}